PATRYS Ltd

AU PAB

0.032AUD
-(-%)

Last update at 2026-03-13T01:17:00Z

Day Range

0.030.03
LowHigh

52 Week Range

0.010.05
LowHigh

Fundamentals

  • Previous Close 0.03
  • Market Cap10.90M
  • Volume289820
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-4.15999M
  • Revenue TTM0.10M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.10M
  • Diluted EPS TTM-0.02

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax -3.01330M -4.82419M -7.06162M -6.78036M -4.06292M
Minority interest - - - - -
Net income -3.01330M -3.53915M -7.06162M -6.78036M -4.06292M
Selling general administrative 1.78M 1.86M 2.39M 2.03M 2.54M
Selling and marketing expenses - - - - -
Gross profit 0.83M 1.39M - 0.03M 0.03M
Reconciled depreciation 0.05M 0.05M 0.05M 0.05M 0.05M
Ebit -2.70955M -3.53915M -9.96052M -10.13399M -5.42236M
Ebitda -2.66025M -3.49215M -9.91353M -10.08644M -5.37380M
Depreciation and amortization 0.05M 0.05M 0.05M 0.05M 0.05M
Non operating income net other - - - - -
Operating income -2.70955M -3.53915M -9.96052M -6.78036M -4.06292M
Other operating expenses 3.54M 4.93M 9.96M 10.11M 5.40M
Interest expense - - - 0.00810M 0.00000M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.02M 0.11M 0.08M 0.00810M 0.00530M
Net interest income 0.02M 0.11M 0.08M 0.00810M 0.00530M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.80727M -1.28504M -0.12386M -0.05565M -0.05386M
Total revenue 0.83M 1.39M 2.85M 0.03M 0.03M
Total operating expenses 3.54M 4.93M 9.96M 10.16M 5.45M
Cost of revenue - 0.05M - - -
Total other income expense net -0.30375M -1.28504M 2.78M 3.30M 1.31M
Discontinued operations - - - - -
Net income from continuing ops -3.01330M -3.53915M -7.06162M -6.78036M -4.06292M
Net income applicable to common shares -3.01330M -3.53915M -7.06162M -6.78036M -4.06292M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 1.74M 4.16M 7.52M 13.97M 12.89M
Intangible assets - 0.35M 0.39M 0.44M 0.48M
Earning assets - - - - -
Other current assets - 0.23M - 0.29M 0.21M
Total liab 1.01M 0.69M 0.69M 0.54M 0.85M
Total stockholder equity 0.73M 3.47M 6.84M 13.43M 12.04M
Deferred long term liab - - - - -
Other current liab - 0.45M 0.40M 0.38M 0.55M
Common stock - 85.73M 85.73M 85.72M 78.11M
Capital stock 86.01M 85.73M 85.73M 85.72M 78.11M
Retained earnings -86.17015M -83.87425M -81.11944M -74.29633M -67.51839M
Other liab - - - - -
Good will - - - - -
Other assets - 0.00000M - - -
Cash 0.74M 2.24M 3.05M 7.82M 6.92M
Cash and equivalents - - - - 6.92M
Total current liabilities 1.01M 0.69M 0.69M 0.54M 0.85M
Current deferred revenue - - - - -
Net debt - -2.24066M -3.04552M -7.81784M -6.91660M
Short term debt - - 0.00000M 0.00000M 0.00000M
Short long term debt - - - - -
Short long term debt total - - - - -
Other stockholder equity - 0.00000M -4.61070M -11.42736M -10.59365M
Property plant equipment - - 0.00167M 0.00366M 0.00392M
Total current assets 1.74M 3.81M 7.13M 13.53M 12.40M
Long term investments - - - - -
Net tangible assets - - 6.44M 12.99M 11.56M
Short term investments - - 1.00M 2.00M 4.00M
Net receivables - 1.34M 2.84M 3.41M 1.28M
Long term debt - - - - -
Inventory - - - - -
Accounts payable 0.14M 0.24M 0.29M 0.16M 0.30M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - 1.61M 2.23M 2.00M 1.45M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - -0.00000M -0.39542M -0.44241M -0.48767M
Deferred long term asset charges - - - - -
Non current assets total 0.00000M 0.35M 0.40M 0.44M 0.49M
Capital lease obligations - - - - -
Long term debt total - - 0.00000M 0.00000M 0.00000M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments 0.00000M 1.01M 1.00M 2.00M -4.00000M
Change to liabilities - - 0.11M -0.13620M 0.22M
Total cashflows from investing activities 0.00000M 1.01M 1.00M 1.99M -4.00389M
Net borrowings - - - - -
Total cash from financing activities 0.28M 0.00429M 0.00645M 7.56M 11.05M
Change to operating activities - - 0.08M -0.24834M 0.10M
Net income -3.01330M -3.53915M -7.06162M -6.78036M -4.06292M
Change in cash -1.49822M -0.80485M -4.77233M 0.90M 2.94M
Begin period cash flow 2.24M 3.05M 7.82M 6.92M 3.98M
End period cash flow 0.74M 2.24M 3.05M 7.82M 6.92M
Total cash from operating activities -1.77418M -1.81594M -5.77882M -8.67921M -3.87716M
Issuance of capital stock 0.31M 0.00429M 0.00645M 7.90M 11.69M
Depreciation 0.05M 0.05M 0.05M 0.05M 0.05M
Other cashflows from investing activities 0.00000M 1.01M 1.00M 2.00M -4.00000M
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables 0.52M 1.50M 0.57M -2.13399M -0.58930M
Sale purchase of stock -0.03240M 0.00429M 0.00645M -0.34520M -0.63623M
Other cashflows from financing activities - 1.01M 1.00M 1.99M -4.00389M
Change to netincome - - 0.47M 0.57M 0.41M
Capital expenditures 0.00000M 0.00324M 0.00000M 0.00229M 0.00389M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.33M 1.57M 0.57M -2.13399M -0.58930M
Stock based compensation - 0.16M 0.47M 0.57M 0.27M
Other non cash items 0.86M -0.05787M 1.24M -1.94640M 0.14M
Free cash flow -1.77418M -1.81917M -5.77882M -8.68150M -3.88104M

Peer Comparison

Sector: Industry:

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
PAB
PATRYS Ltd
- -% 0.03 - - 108.62 24.09 1358.78 -3.8529
CBAPI
Commonwealth Bank of Australia
-0.35 0.34% 101.10 - - - -
CGFPC
Challenger Ltd
-0.2 0.20% 100.00 - - - -
RF1
Regal Investment Fund
0.02 0.57% 3.50 - - - -
RG1
Regal Partners Global Investments Limited
-0.02 0.91% 2.19 - - - -

Reports Covered

Stock Research & News

Profile

Patrys Limited, together with its subsidiaries, develops antibody technologies for the treatment of cancer and NETosis-driven inflammatory diseases. It develops PAT-DX1, a small antibody fragment derived from a humanized version of the binding domain from the original mouse deoxymab antibody 3E10; and PAT-DX3 for treating primary and secondary brain cancers, and metastases that are associated with NETosis, or in combination with DNA damaging agents, such as radiation and other chemotherapy drugs. The company was incorporated in 2006 and is based in Nedlands, Australia.

PATRYS Ltd

168 Stirling Highway, Nedlands, WA, Australia, 6009

Key Executives

Name Title Year Born
Dr. James A. Campbell B.Sc., MBA, Ph.D. MD, CEO & Exec. Director NA
Ms. Valentina Dubljevic BSc, GAICD, MBB VP of Scientific & Clinical Devel. NA
Dr. Deanne Greenwood B.Sc., GAICD, MBA, Ph.D. VP of Bus. Devel. & Intellectual Property NA
Dr. Rebecca Tunstall VP of Corp. Devel. NA
Mr. Stefan Ross Company Sec. NA
Dr. James A. Campbell B.Sc., MBA, Ph.D. MD, CEO & Executive Director NA
Mr. Stefan Ross Company Secretary NA
Dr. Rebecca Tunstall Vice President of Corporate Development NA
Dr. James A. Campbell B.Sc., MBA, Ph.D. MD, CEO & Executive Director NA
Mr. Stefan Ross Company Secretary NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.